Effects of captopril and ticlopidine, alone or in combination, in hypertensive patients with intermittent claudication

International Angiology

Volumn 15, Issue 2, 1996, Pages 169-174

  Novo, S ^c,d   Abrignani, M G ^a   Pavone, G ^b   Zamueli, M ^b   Pernice, C ^b   Geraci, A M ^b   Longo, B ^a   Caruso, R ^a   Strano, A ^c  

^a Hospital of Trapani   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d NONE   (Italy)

Author keywords

Arterial hypertension; Blood pressure; Captopril; Claudicatio intermittent; Peripheral arterial disease; Ticlopidine

Indexed keywords

ANTITHROMBOCYTIC AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; TICLOPIDINE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; DIARRHEA; HUMAN; HYPERTENSION; INTERMITTENT CLAUDICATION; MALE; NAUSEA; PRURITUS; VERTIGO; WALKING;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CAPTOPRIL; DRUG THERAPY, COMBINATION; HUMANS; HYPERTENSION; INTERMITTENT CLAUDICATION; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; TICLOPIDINE; TIME FACTORS;

EID: 0030003269     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Robertson JIS, Tillman DM. Converting enzyme inhibitors in the treatment of hypertension. J Cardiovasc Pharmacol 1987;10:(Suppl 7):S43-S48.
2. Cleland JGF. The clinical course of heart failure and its modification by ACE inhibitors: insights from recent clinical trials. Eur Heart J 1994;15:125-30.
3. Ondetti MA. Structural relationship of ACE inhibitors to pharmacologic activity. Circulation 1988;77:74-8.
4. Fitzpatrick A, Julius S. Hemodinamic effects of angiotensinconverting enzyme inhibitors in essential hypertension: a review. J Cardiovasc Pharmacol 1985;7(Suppl 1):S35-S39.
5. Nussberger J, Biolla J, Waeber B, Brummer HB. Chronic treatment of hypertensive patients with converting enzyme inhibitors. J Cardiovasc Pharmacol 1986;8(Suppl 1):20-5.
6. Di Minno G, Cerbone AM, Mattioli PL, Turco S, Jovine C, Mancini M. Functionally thrombasthenic state in normal platelets following the administration of ticlopidine. J Clin Invest 1985;75:328-32.
7. Saltiel E, Ward A, Ticlopidine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in platelet-dependent disease states. Drug 1987;34:222-62.
8. Malfrand JP, Defreyn G, Berrat A, Delebonce D, Tissinier AM. Reviewed pharmacology of ticlopidine. Angiologie 1988;77:6-13.
9. Avellone G, Novo S, Davi G et al. Haemorheological changes induced by ticlopidine in patients suffering from arteriosclerosis obliterans of the lower limbs. In: Strano A, editor. International Conference on Platelet function and cardiovascular diseases. Amsterdam: Excerpta Medica 1984:187-92.
10. Frolich ED, Grim C, Labarthe DR. Recommendations for human blood pressure determination by sphygmomanometers. Circulation 1988;77:502A-514A.
11. 1993 Guidelines for the management of mild hypertension memorandum from a WHO/ISF meeting. High Blood Press Cardiovasc Prevent 1993;2:169-86.
12. Winsor T. Influence of arterial disease on the systolic blood pressure gradient of extremity. Am J Med Sci 1950;220:117-8.
13. Novo S, Avellone G, Di Garbo V et al. Prevalence of risk factors in patients with peripheral arterial disease: a clinical and epidemiological evaluation. Int Angiol 1992;11:218-29.
14. Andreani D, Bell P, Bollinger A et al. Second European Consensus Document on Chronic Critical Leg Ischemia. Circulation 1991;84(Suppl 4):1-26.
15. Novo S, Pinto A, Licata G et al. Captopril induced modifications of systemic haemodynamics and of arterial flow at the calf in the patients with essential hypertension. Eur Rev Med Pharmacol Sci 1983;4:457-63.
16. Strano A, Novo S, Salerno L et al. Haemodynamic and antihypertensive effects of captopril in patients with essential hypertension. Drug Clin Exptl Res 1982; 8:323-7.
17. Catalane M, Libretti A. Captopril for the treatment of patients with hypertension and peripheral vascular disease. Angiology 1985;36:293-6.
18. Novo S, Abrignani MG, Pinto A, Strano A. Regression of structural vascular changes in hypertensives after captopril treatment. Eur Heart J 1992;13:1135-7.
19. Saku K, Zhang B, Jimi S, Takebayashi S, Arakawa K. Captopril suppresses atherosclerosis in cholesterol fed rabbits without affecting lipids an insulin. J Hypertens 1994;12(Suppl 3):S139 (Abstract 766).
20. Arcan JC, Blanchard J, Boissel JP, Destors JM, Panak E. Multicenter double-blind study of ticlopidine in the treatment of intermittent claudication and the prevention of its complications. Angiology 1988;39:802-11.
21. Janzon L, Lindgarde F, Pesson G et al. Prevented progression of leg arteriosclerosis with Ticlopidine. Angiology 1988;77:21-4.
22. Balsano F, Coccheri S, Libretti A et al. Ticlopidine in the treatment of intermittent claudication: A 21 months double blind trial. J Lab Clin Med 1989;114:84-91.
23. Boissel JP, Destors JM, Peyrieux JC, Panak E. Ticlopidine in intermittent claudication. A metaanalysis. Angiologie 1988;77:32-3.
24. Hess H, Mietaschk A, Deichsel G. Drug-induced inhibition of platelet function delays progression of peripheral occlusive arterial disease. Lancet 1985;8426:415-9.
25. Strano A, Novo S, Davi G, Avellone G, Pinto A. Haemostatic alterations in peripheral arteriopathies. In: Cajozzo A, Perricone R, Di Marco P, Palazzolo P, editors. Advances in haemostasis and thrombosis. London: Plenum Publishing Corporation 1985:213-22.
26. Swaled JD. ACE inhibitors and the quality of life. J Cardiovasc Pharmacol 1987;9(Suppl 3):S22-S25.
27. Strano A, Novo S, Licata G et al. Asymptomatic and symptomatic carotid and peripheral arterial disease in patients suffering from CHD: factors affecting the progression of atherosclerosis. In: Boccalon M, editor. Vascular Medicine Elsevier 1993:275-8.
28. Novo S. The patient with intermittent claudication. In: Bloch Thmsen PE, Clement DL, editors. Problems in clinical cardiology. Amsterdam: Excerpta Medica 1995;5,6:3-10.
29. Janzon L, Bergqvist D, Boberg J, Eriksson I, Lindgarde F, Persson G. Prevention of myocardial infarction and stroke in patients with intermittent claudication: effects of Ticlopidine. Results from STIMS, the Swedish Ticlopidine Multicentre Study. J Intern Med 1990; 227:301-8.
30. Blanchard J, Carreras LO, Kindermans M, EMATAP Group. Results of EMATAP: a double-blind placebo-controlled multicentre trial of Ticlopidine in patients with peripheral arterial disease. Nouv Rev Fr Hematol 1993;35:523-8.